Trending Down-0.0200 (-0.6969%)
  • Bid / Lots
    2.8200/ 3
  • Ask / Lots
    2.9300/ 6
  • Open / Previous Close
    2.8300 / 2.8700
  • Day Range
    Low 2.8000
    High 2.9200
  • 52 Week Range
    Low 0.9628
    High 4.0400
  • Volume
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 2.83
09:32 ET38732.83
09:37 ET75002.87
09:39 ET3002.855
09:42 ET68172.82
09:44 ET65112.8629
09:46 ET50002.88
09:48 ET31002.9
09:50 ET32102.9
09:51 ET7002.88
09:53 ET43952.85
09:55 ET2002.83
10:02 ET2002.8672
10:04 ET8002.88
10:06 ET2832.8315
10:08 ET1002.88
10:09 ET1002.88
10:13 ET2002.87
10:18 ET1002.87
10:20 ET20002.85
10:33 ET1002.86
10:40 ET15292.835
10:42 ET3002.84
10:45 ET3002.86
10:47 ET6822.87
10:51 ET15272.86
10:56 ET2002.8606
10:58 ET19302.86
11:03 ET9112.88
11:09 ET13722.88
11:12 ET5592.86
11:14 ET1002.88
11:18 ET7002.86
11:20 ET26002.86
11:21 ET12252.8672
11:25 ET8002.8636
11:32 ET2732.86
11:43 ET20522.87
11:50 ET3002.87
11:57 ET13022.88
12:14 ET54262.85
12:15 ET5002.855
12:30 ET2002.87
01:13 ET1002.86
01:18 ET2002.86
01:38 ET7072.83
01:44 ET1002.8301
01:56 ET1002.86
02:30 ET2002.84
02:34 ET3002.85
02:39 ET1002.86
02:48 ET1992.8423
02:54 ET15102.87
02:56 ET4762.89
02:57 ET67722.89
03:01 ET7302.89
03:03 ET1002.875
03:17 ET1002.89
03:21 ET3002.89
03:32 ET23722.9
03:35 ET9472.87
03:42 ET27222.9
03:46 ET1002.9
03:51 ET1002.9
03:55 ET1002.88
03:57 ET1002.87
04:00 ET35032.85
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesCLLS
Cellectis SA
United StatesFHTX
Foghorn Therapeutics Inc.
United StatesMRSN
Mersana Therapeutics Inc
United StatesGNFT
Genfit SA
United StatesHARP
Harpoon Therapeutics Inc
United StatesZOM
Zomedica Corp
As of 2023-12-05

Company Information

Cellectis SA is a France-based company active in the field of genome engineering and genomic surgery. The Company specializes in the research, development, and commercialization of rational genome engineering technologies. The Company develops immunotherapies that aim to force the immune system to target and eradicate cancer cells. It has developed an expertise in combining meganucleases with engineered targeting Deoxyribonucleic Acid (DNA) matrices into Meganuclease Recombination Systems (MRS), used for gene excision, correction or replacement. Cellectis SA markets its technologies mainly for use in the research field, in pharmaceutical drug discovery programs, in the agronomics, bioproduction, and biotherapeutics fields. Cellectis SA operates several subsidiaries. The Company operates in France and the United States, among others.

Contact Information

8, rue de la Croix JarryPARIS, France 75013


Non-Executive Independent Chairman of the Board
Jean-Pierre Garnier
Chief Executive Officer, Co-Founder, Director, Member of the Executive Board
Andre Choulika
Deputy Chief Executive Officer, Co-Founder, Executive Vice President - CMC and Manufacturing, Director
David Sourdive
Chief Financial Officer, Member of the Executive Board
Bing Wang
Chief Human Resource Officer, Executive Vice President, Member of the Executive Committee
Kyung Nam-Wortman

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
Revenue (TTM)
Shares Outstanding
Dividend Yield
Annual Dividend Rate
Ex-Dividend Date
Pay Date
Book Value
P/E Ratio
Price/Sales (TTM)
Price/Cash Flow (TTM)
Operating Margin
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.